Literature DB >> 15711751

Crotalid venom vascular endothelial growth factors has preferential affinity for VEGFR-1. Characterization of Protobothrops mucrosquamatus venom VEGF.

Yuh-Ling Chen1, Inn-Ho Tsai, Tse-Ming Hong, Shu-Huei Tsai.   

Abstract

Pm-VEGF, a novel member ofVEGF family from the venom gland of Taiwan habu (Protobothrops mucrosquamatu), is a disulfide-linked homodimer with 119 amino acid residues. Recombinant fusion Pm-VEGF was expressed in Escherichia coli, purified and refolded. Surface plasmon resonance was used to determine its binding kinetics toVEGF-receptors (VEGFR). Relative to human VEGF165, the binding affinity of Pm-VEGF to the VEGFR-1 was 1.7-fold higher while affinity to the VEGFR-2 was 17-fold lower. But it did not bind the VEGFR-3 or neuropilin-1. Pm-VEGF promoted the proliferation and tissue factor production of endothelial cells, the neovascularization in the chicken chorioallantoic membrane, and increased vascular permeability. It also stimulated tissue-factor production and human monocyte chemotaxis, in accord with its specificity for VEGFR-1. Structural comparison among VEGF-proteins from various viper venoms revealed that the two subfamilies of vipers (Crotalinae and Viperinae) have evolved with distinct receptor-specificities for VEGFR-1 and VEGFR-2, respectively. Discussion on structure-activity relationships of the VEGFs further provided insight into residues important for the receptor-binding and specificities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15711751     DOI: 10.1160/TH04-09-0568

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Snake venom Vascular Endothelial Growth Factors (VEGF-Fs) exclusively vary their structures and functions among species.

Authors:  Yasuo Yamazaki; Yukiko Matsunaga; Yuko Tokunaga; Shinya Obayashi; Mai Saito; Takashi Morita
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

Review 2.  Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy.

Authors:  Gang Niu; Xiaoyuan Chen
Journal:  Curr Drug Targets       Date:  2010-08       Impact factor: 3.465

Review 3.  Molecular and functional diversity of vascular endothelial growth factors.

Authors:  Yasuo Yamazaki; Takashi Morita
Journal:  Mol Divers       Date:  2006-11       Impact factor: 3.364

4.  Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.

Authors:  Marco Rusnati; Antonella Bugatti; Stefania Mitola; Daria Leali; Paolo Bergese; Laura E Depero; Marco Presta
Journal:  Sensors (Basel)       Date:  2009-08-20       Impact factor: 3.576

5.  Quantitative high-throughput profiling of snake venom gland transcriptomes and proteomes (Ovophis okinavensis and Protobothrops flavoviridis).

Authors:  Steven D Aird; Yutaka Watanabe; Alejandro Villar-Briones; Michael C Roy; Kouki Terada; Alexander S Mikheyev
Journal:  BMC Genomics       Date:  2013-11-14       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.